author-photo

David Žihala

University of Ostrava

14

Papers

93

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Circulating Plasma Cells Are the Most Powerful Prognostic Marker in Transplant Ineligible Multiple Myeloma with 2% As a New Cut-Off for Primary Plasma Cell Leukemia

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
PhyloFisher: A phylogenomic package for resolving eukaryotic relationships.

2021 PLOS Biology
Show All
- Source
- Cite
- Save
Citations (3)
Limited efficacy of daratumumab in multiple myeloma with extramedullary disease.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (2)
OAB-035: Minimally invasive profiling of tumor and immune cells to stratify risk in smoldering multiple myeloma (SMM): the iMMunocell study

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Pathogenesis of Extramedullary Multiple Myeloma: From Resistance to Identification of Novel Therapeutic Targets

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Evolution of the genetic code in the mitochondria of Labyrinthulea (Stramenopiles).

2020 Molecular Phylogenetics and Evolution
Show All
- Source
- Cite
- Save
Citations (2)
Genomics of New Ciliate Lineages Provides Insight into the Evolution of Obligate Anaerobiosis.

2020 Current Biology
Show All
- Source
- Cite
- Save
Citations (15)
Identification of Novel Regulatory Pathway for Immunoglobulin Production Provides Rational Treatment for Bortezomib-Resistant Multiple Myeloma Patients

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Identification of Molecular Mechanisms Responsible for the Development of Extramedullary Disease in Myeloma and Potential Novel Therapeutic Targets Using Transcriptomic and Exome Profiling

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)